BRCA1 and familial pancreatic carcinoma: The majority of studies examining the prevalence of pancreatic cancer in BRCA1 mutated patients have shown no increased risk, however, others have estimated a 2- to 2.5-fold increased risk (Thompson et al., 2002; Ferrone et al., 2009).